Poly Medicure Limited (NSE:POLYMED)
1,334.20
+51.00 (3.97%)
Apr 2, 2026, 3:30 PM IST
Poly Medicure Revenue
Poly Medicure had revenue of 4.94B INR in the quarter ending December 31, 2025, with 16.37% growth. This brings the company's revenue in the last twelve months to 17.82B, up 10.86% year-over-year. In the fiscal year ending March 31, 2025, Poly Medicure had annual revenue of 16.70B with 21.37% growth.
Revenue (ttm)
17.82B
Revenue Growth
+10.86%
P/S Ratio
7.60
Revenue / Employee
5.78M
Employees
3,082
Market Cap
135.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.70B | 2.94B | 21.37% |
| Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
| Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
| Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
| Mar 31, 2021 | 7.86B | 992.31M | 14.44% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Alembic Pharmaceuticals | 72.67B |
| Indegene | 32.63B |
| Alivus Life Sciences | 25.12B |
| Dr. Agarwal's Health Care | 19.76B |
Poly Medicure News
- 5 months ago - Poly Medicure Ltd (BOM:531768) Q2 2026 Earnings Call Highlights: Strategic Acquisitions and ... - GuruFocus
- 5 months ago - Q2 2026 Poly Medicure Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Poly Medicure acquires Italy’s Citieffe for Rs 324 crore - Business Upturn
- 8 months ago - Poly Medicure cuts FY26 export growth guidance to 5-10% from 15-18% earlier - Business Upturn
- 8 months ago - Poly Medicure Q1 Results: Revenue jumps 4.8% YoY to 403.21 crore, net profit up 25.8% YoY - Business Upturn
- 11 months ago - Poly Medicure shares surge 3% as Q4 revenue rises 16.6% YoY to Rs 441 crore - Business Upturn
- 1 year ago - Poly Medicure shares surge over 6% as Trump tariffs target Chinese medical imports; imposed 245% tariffs on syringes and needles - Business Upturn
- 1 year ago - Poly Medicure Ltd (BOM:531768) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus